Racial disparities within Basal-type breast cancer: clinical and molecular features of African American and Caucasian obese patients

PUBLICATION: SABCS 2020 AUTHORS: Dipali Sharma, Lisa E. Blumencranz, Heather Read More

2020-12-29T09:09:46-08:00December 29th, 2020|Evidence|

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

PUBLICATION: SABCS 2020 AUTHORS: Joseph McKelley, Jennifer Wei, Brian Hoxeng, Read More

2020-12-29T09:01:39-08:00December 29th, 2020|Evidence|

Differential gene expression in Luminal type invasive lobular carcinoma and invasive ductal carcinoma by MammaPrint risk stratification

PUBLICATION: SABCS 2020 AUTHORS: Beth-Ann Lesnikoski, Jennifer A. Crozier, Gordan Read More

2020-12-29T08:55:20-08:00December 29th, 2020|Evidence|

Molecular subtyping by BluePrint improves prediction of treatment responses and survival outcomes in patients with discordant clinical and genomic classification

PUBLICATION: SABCS 2020 AUTHORS: Pat Whitworth, James V Pellicane, Jr., Read More

2020-12-29T08:46:42-08:00December 29th, 2020|Evidence|

The FLEX real world data platform explores new gene expression profiles and investigator-initiated protocols in early stagebreast cancer

PUBLICATION: SABCS 2020 AUTHORS: Laura Lee, Sami Diab, Julie Barone, Read More

2020-12-29T08:32:41-08:00December 29th, 2020|Evidence, Uncategorized|
Go to Top